Chapter 1 Allocating Cancer-Directed Expenditures: Tensions Between Prevention, Early Detection and Treatment is Unnecessary

Chapter 2 Lessons Learned from Prevention Programs: Different Endpoints Should Be Used in Secondary and Tertiary Prevention

Chapter 3 Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities

Chapter 4 Targeting polyamines and inflammation for cancer prevention.

Chapter 5 Thinking About the Role (Largely Ignored) of Heavy Metals in Cancer Prevention: Hexavalent Chromium and Melanoma as a Case in Point

Chapter 6 Clinical Cancer Prevention

Chapter 7 Chemoprevention of Hepatocellular Carcinoma in Chronic Hepatitis C

Chapter 8 Nutritional Aspects of Primary Prostate Cancer Prevention

Chapter 9 Prostate Cancer Prevention with 5 Alpha-Reductase Inhibitors

Chapter 10 Hormone replacement therapy and breast cancer.

Chapter 11 Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms.

Chapter 13 Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed